483 Jiangsu Hengrui Medicine Nov 2016

483 Jiangsu Hengrui Medicine Nov 2016

Peter Baker FDA, Christopher Middendorf FDA$119.00 - Available Now

FDA investigators audited the Jiangsu Hengrui Medicine - Lianyungang, China facility and issued inspectional observations (via FDA 483) on 02 Nov 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Nov 2016
  • Location: Lianyungang, China
  • FEI: 3007373503
Add To Cart